Aase H. Hensvold
Solna, AB, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 48 publications
TNF-α blockade with adalimumab restores bone metabolism in rheumatoid arthritis by regulating cytokines and inflammatory cell infiltration.
Journal: Frontiers in immunology
Published: April 27, 2026
Ultrasound-defined presynovitis is associated with progression to clinical arthritis in ACPA-positive individuals at risk of rheumatoid arthritis: longitudinal insights from the Karolinska Risk-RA cohort.
Journal: Annals of the rheumatic diseases
Published: February 18, 2026
Serum test for secretory component-containing anti-citrullinated protein antibodies as a novel prognostic tool in rheumatoid arthritis at-risk subjects.
Journal: Journal of translational autoimmunity
Published: July 25, 2025
Novel Biomarker for Rheumatoid Arthritis: Serum Peptidylarginine Deiminase 4-Potentiating Activity in an Anti-Citrullinated Protein Antibody-Positive At-Risk Population.
Journal: Scandinavian journal of immunology
Published: May 19, 2025
Innate immune cell subsets are enriched in synovial fluid of ACPA-negative rheumatoid arthritis and characterized by distinct type I IFN gene signatures.
Journal: Annals of the rheumatic diseases
Published: January 29, 2025
Porphyromonas gingivalis associates with the presence of anti-citrullinated protein antibodies, but not with the onset of arthritis: studies in an at-risk population.
Journal: RMD open
Published: October 10, 2024
Rheumatoid Arthritis Related B-Cell Changes Are Found Already in the Risk-RA Phase.
Journal: European journal of immunology
Published: July 15, 2024
Arthritis progressors have a decreased frequency of circulating autoreactive T cells during the at-risk phase of rheumatoid arthritis.
Journal: RMD open
Published: May 09, 2024
Macrophage activation and inflammatory priming by anti-MAA antibodies in rheumatoid arthritis.
Journal: Clinical immunology (Orlando, Fla.)
Published: March 28, 2024
Autoreactive B cells against malondialdehyde-induced protein cross-links are present in the joint, lung, and bone marrow of rheumatoid arthritis patients.
Journal: The Journal of biological chemistry
Published: August 24, 2023
Identification of early risk factors for anti-citrullinated-protein-antibody positive rheumatoid arthritis-a prospective cohort study.
Journal: Rheumatology (Oxford, England)
Published: July 11, 2023
Last Updated: 09/26/2026